Form 4 for ORIC Oric Pharmaceuticals, Inc.
Accepted 2023-12-19 00:00:00 ET · period of report 2023-12-15 · accession 0001209191-23-059266 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-19 | 2023-12-15 | ORIC | Multani Pratik S | Chief Medical Off | M - OptEx | $0.00 | +14.0K | 29.1K | +93% | $0 |
| D | 2023-12-19 | 2023-12-15 | ORIC | Multani Pratik S | Chief Medical Off | S - Sale+OE | $8.59 | -5,282 | 23.8K | -18% | -$45.4K |
| DM | 2023-12-19 | 2023-12-15 | ORIC | Multani Pratik S | Chief Medical Off | M - OptEx | $0.00 | -14.0K | 16.0K | -47% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-15 | M | A | 14,042 | $0.00 | 29,091 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock. (F2) Includes an aggregate of 7,764 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2023-12-15 | S | D | 5,282 | $8.59 | 23,809 | D | — | — | (F4) Represents the weighted average share price of an aggregate total of 5,282 shares sold in the price range of $8.57 to $8.795 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Derivative | Restricted Stock Unit | 2023-12-15 | M | D | 6,042 | $0.00 | 6,042 | D | — · — to — | 6,042 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock. (F5) 1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024. |
| 4 | Derivative | Restricted Stock Unit | 2023-12-15 | M | D | 8,000 | $0.00 | 16,000 | D | — · — to — | 8,000 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock. (F6) 1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025. |